E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/19/2008 in the Prospect News Bank Loan Daily and Prospect News High Yield Daily.

S&P: Symbion unchanged

Standard & Poor's said its BBB- ratings and negative outlook on Symbion Health Ltd. are unchanged after Primary Health Care Ltd. (not rated) moved to more than 50% ownership of Symbion and the takeover offer became unconditional.

The negative outlook reflects the uncertainty surrounding Symbion's final business mix and the refinancing of the company's A$680 million of bank loans, the agency said.

S&P noted that while Symbion's half-year results showed improvements in the underlying financial performance of the company, a number of cost-pressure challenges remain.

For the six months ended Dec. 31, the agency said that Symbion improved overall operating margins to 7.5%, compared with 7.1% for the full year to June 30, 2007.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.